Short answer first, then the reasoning. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
So the question, as narrowly as I can put it: how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Numbers rather than impressions, if you have them.
mike.trainer_LA said:There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsSurmountFan_IN said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Mine went the same way, slower. Nothing to add that would improve it.
Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.